Kara Hoisington

NPI: 1588877419
Total Payments
$303,208
2024 Payments
$250.56
Companies
42
Transactions
987
Medicare Patients
1,210
Medicare Billing
$87,477

Payment Breakdown by Category

Other$263,685 (87.0%)
Travel$15,224 (5.0%)
Food & Beverage$15,016 (5.0%)
Consulting$8,994 (3.0%)
Education$289.60 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $263,685 159 87.0%
Travel and Lodging $15,224 119 5.0%
Food and Beverage $15,016 689 5.0%
Consulting Fee $8,994 6 3.0%
Education $289.60 14 0.1%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $106,105 350 $0 (2024)
SANOFI-AVENTIS U.S. LLC $62,678 128 $0 (2023)
AstraZeneca Pharmaceuticals LP $56,597 130 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $34,075 81 $0 (2020)
Lilly USA, LLC $21,359 67 $0 (2024)
Amgen Inc. $15,993 73 $0 (2022)
Corcept Therapeutics $3,732 19 $0 (2019)
Medtronic MiniMed, Inc. $287.36 4 $0 (2019)
Insulet Corporation $284.28 4 $0 (2022)
Merck Sharp & Dohme Corporation $212.96 21 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $250.56 18 Novo Nordisk Inc ($167.31)
2023 $2,771 54 Novo Nordisk Inc ($2,314)
2022 $21,290 73 Novo Nordisk Inc ($18,486)
2021 $34,766 94 Novo Nordisk Inc ($15,028)
2020 $37,766 123 Novo Nordisk Inc ($17,164)
2019 $80,947 223 SANOFI-AVENTIS U.S. LLC ($22,023)
2018 $82,632 220 Novo Nordisk Inc ($32,273)
2017 $42,785 182 AstraZeneca Pharmaceuticals LP ($15,012)

All Payment Transactions

987 individual payment records from CMS Open Payments — Page 1 of 40

Date Company Product Nature Form Amount Type
12/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.89 General
Category: Diabetes
10/18/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $9.55 General
Category: Diabetes
10/17/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $12.66 General
Category: Diabetes
07/24/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.45 General
Category: Diabetes
06/07/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.88 General
Category: Diabetes
06/06/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.92 General
Category: Diabetes
05/14/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Education In-kind items and services $13.76 General
Category: INTERNAL MEDICINE
05/07/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $11.56 General
Category: Diabetes
04/26/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $12.02 General
Category: Diabetes
04/17/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $18.43 General
Category: Cardio-renal
04/09/2024 IBSA Pharma Inc. Tirosint (Drug), Licart Food and Beverage Cash or cash equivalent $16.75 General
Category: Endocrinology
04/03/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $6.20 General
Category: Diabetes
04/02/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $9.76 General
Category: Diabetes
03/14/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $14.65 General
Category: Diabetes
02/21/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $10.48 General
Category: Diabetes
02/15/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $11.29 General
Category: Diabetes
01/24/2024 Lilly USA, LLC JARDIANCE (Drug), ZEPBOUND Food and Beverage In-kind items and services $18.20 General
Category: Diabetes
01/24/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $16.11 General
Category: PAIN MANAGEMENT
12/07/2023 Tolmar, Inc. JATENZO (Drug) Food and Beverage In-kind items and services $13.31 General
Category: Endogenous Testosterone Replacement Therapy
11/28/2023 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $7.78 General
Category: PAIN MANAGEMENT
11/22/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $23.19 General
Category: Diabetes Care
10/30/2023 SANOFI-AVENTIS U.S. LLC TOUJEO (Biological) Food and Beverage In-kind items and services $24.22 General
Category: Endocrine & Metabolic Diseases
10/25/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $14.66 General
Category: Diabetes
10/25/2023 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $8.84 General
Category: PAIN MANAGEMENT
10/20/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $17.92 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 228 309 $29,839 $17,532
2022 4 229 312 $30,634 $17,366
2021 4 244 323 $36,690 $17,925
2020 9 509 1,293 $71,836 $34,653
Total Patients
1,210
Total Services
2,237
Medicare Billing
$87,477
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 103 158 $16,676 $10,621 63.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 35 48 $7,382 $4,787 64.8%
76536 Ultrasound scan of head and neck soft tissue Facility 2023 75 80 $4,240 $1,541 36.4%
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report Office 2023 15 23 $1,541 $583.44 37.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 121 182 $20,573 $12,341 60.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 17 25 $4,106 $2,657 64.7%
76536 Ultrasound scan of head and neck soft tissue Facility 2022 76 79 $4,187 $1,649 39.4%
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report Office 2022 15 26 $1,768 $718.96 40.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 129 182 $24,470 $12,175 49.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 25 33 $6,061 $3,417 56.4%
76536 Ultrasound of head and neck Facility 2021 73 79 $4,187 $1,599 38.2%
95251 Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours Office 2021 17 29 $1,972 $734.48 37.2%
J0897 Injection, denosumab, 1 mg Office 2020 13 780 $17,160 $11,665 68.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 109 114 $16,644 $6,810 40.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 86 89 $12,994 $5,250 40.4%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 37 38 $4,554 $2,472 54.3%
76536 Ultrasound of head and neck Facility 2020 101 105 $5,565 $2,302 41.4%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 22 22 $4,312 $1,727 40.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 16 18 $3,528 $1,619 45.9%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 24 24 $3,504 $1,475 42.1%
95251 Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours Facility 2020 17 19 $1,369 $524.32 38.3%
95251 Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours Office 2020 13 13 $968.00 $287.29 29.7%
83036 Hemoglobin a1c level Office 2020 29 29 $667.00 $276.08 41.4%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 16 16 $467.00 $164.77 35.3%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2020 26 26 $104.00 $80.91 77.8%

About Kara Hoisington

Kara Hoisington is a Internal Medicine healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588877419.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kara Hoisington has received a total of $303,208 in payments from pharmaceutical and medical device companies, with $250.56 received in 2024. These payments were reported across 987 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($263,685).

As a Medicare-enrolled provider, Hoisington has provided services to 1,210 Medicare beneficiaries, totaling 2,237 services with total Medicare billing of $87,477. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Diabetes & Metabolism
  • Location Lansing, MI
  • Active Since 05/07/2007
  • Last Updated 05/04/2011
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1588877419

Products in Payments

  • JARDIANCE (Drug) $54,830
  • Ozempic (Drug) $43,595
  • FARXIGA (Drug) $43,026
  • TOUJEO (Drug) $23,103
  • RYBELSUS (Drug) $18,946
  • SOLIQUA (Drug) $17,838
  • Prolia (Biological) $15,752
  • BYDUREON (Drug) $13,463
  • Rybelsus (Drug) $9,766
  • Tresiba (Drug) $9,290
  • SOLIQUA 100/33 (Drug) $8,237
  • Victoza (Drug) $7,450
  • SOLIQUA 100/33 (Biological) $7,058
  • TOUJEO (Biological) $6,420
  • Korlym (Drug) $3,732
  • Omnipod (Device) $284.28
  • Saxenda (Drug) $213.11
  • JANUVIA (Drug) $212.96
  • Qutenza (Drug) $193.62
  • V-GO (Device) $188.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Lansing